Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

22%

2 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

2(33.3%)

Phase 2

2(33.3%)

Phase 4

2(33.3%)

6Total

N/A(2)

Phase 2(2)

Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT04936581Recruiting

Patient Reported Outcomes Following Cancer of the Rectum

Role: collaborator

NCT06043206Completed

Bariatric Surgery in Patients With Schizophrenia

Role: collaborator

NCT05138094Not ApplicableUnknown

LIVACOR Trial: Minimally Invasive LIVer And Simultaneous COlorectal Resection

Role: collaborator

NCT04623177Completed

Thromboprophylaxis for Patients in ICU With COVID-19

Role: collaborator

NCT04055363Not ApplicableCompleted

Human Milk Oligosaccharides (HMOs) Post-market Study on Infants

Role: collaborator

NCT02104440Phase 2Completed

Clinical Trial In The Treatment Of Allogeneic Post-Transplant Cytopenias With Sequential Infusion Of Allogeneic Mesenchymal Cells Expanded In Vitro

Role: collaborator

NCT01181414Phase 4Completed

Spanish Atrial Fibrillation And Resynchronization Study

Role: collaborator

NCT01592032Phase 4Unknown

Concentration of Antimicrobials in Catheter-lock Solutions

Role: collaborator

NCT00530140Phase 2Unknown

Idiotypic Vaccination for Follicular Lymphoma Patients

Role: collaborator

All 9 trials loaded